Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Intertek Expands GLP Bioanalytical Centre of Excellence In San Diego, California

10/21/2015
Intertek, a leading global quality solutions provider, launched its expanded GLP Bioanalytical Centre of Excellence in San Diego, California. The facility is designed to deliver world-class bioanalysis services to clients around the globe.

According to company officials, its expansion in capacity and new technology of the San Diego facility, which spans 46,000 square feet of laboratories, offices and sample storage, will benefit customers involved in preclinical and clinical development of small molecule drugs and biologic medicines. Investment in new bioanalytical technologies further strengthens capabilities to expedite delivery of fast and cost-effective bioanalysis results for global clients.

Mark Hammond, Intertek Pharmaceutical Services Business Leader said, “Our expanded GLP Bioanalytical Centre of Excellence in San Diego and new technologies provide a broader range of bioanalytical, biomarker, and cell-based capabilities services to meet our clients’ needs in preclinical and clinical bioanalysis, helping them to understand the safety, efficacy and mechanism of action of their small and large molecule drugs in development.”

Chetan Parmar, Senior Vice President of Intertek Life Sciences, said, “With recent expansion in bioanalytical capabilities in both the US and Europe, we further strengthen our capability to address the challenges our clients encounter during drug development through delivery of excellent global bioanalytical services."

The facility offers new technologies such as flow cytometry which will provide clients with robust and comprehensive analysis of cells to help understand the mechanism of action of drugs and facilitate evaluation of drug stability and potency. Furthermore, flow cytometry opens up an additional platform for assessing cell based neutralizing antibody activity in clinical trials, which is important in assessing any potential adverse immunological effects.

Luminex, another new technology at this site, will build on current high throughput and multiplexing capabilities to allow customised measurement of up to 100 analytes simultaneously using very small volumes of sample, officials said. This is ideal for studies where there is limited sample volume. Additional investment in new state-of-the-art liquid chromatography- mass spectrometry instruments not only upgrade Intertek's small molecule bioanalysis capabilities but also improve sensitivity and mass range for analysis of protein therapeutics.

Share

Exclusive Research